Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,927 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09).
Kim M, Kim YJ, Suh KJ, Kim SH, Kim JE, Jeong J, Hong JY, Lee J, Lee SJ, Oh SY, Kim JH, Lee GW, Ahn MS, Choi W, Choi YJ, Lee T, Oum C, Kim J, Kim YS, Ahn JH. Kim M, et al. Among authors: kim yj, kim sh, kim ys, kim je, kim j, kim jh. Cancer. 2024 Oct 18. doi: 10.1002/cncr.35609. Online ahead of print. Cancer. 2024. PMID: 39422602
Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06).
Lee SJ, Kim TM, Kim YJ, Jang KT, Lee HJ, Lee SN, Ahn MS, Hwang IG, Lee S, Lee MH, Lee J. Lee SJ, et al. Among authors: kim yj, kim tm. Oncologist. 2015 Nov;20(11):1312-9. doi: 10.1634/theoncologist.2015-0161. Epub 2015 Sep 30. Oncologist. 2015. PMID: 26424760 Free PMC article. Clinical Trial.
Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.
Suh KJ, Kim SH, Lee KH, Kim TY, Kim YJ, Han SW, Kang E, Kim EK, Kim K, No JH, Han W, Noh DY, Lee M, Kim HS, Im SA, Kim JH. Suh KJ, et al. Among authors: kim yj, kim sh, kim ty, kim ek, kim hs, kim k, kim jh. Cancer Res Treat. 2017 Oct;49(4):1153-1163. doi: 10.4143/crt.2016.463. Epub 2017 Feb 27. Cancer Res Treat. 2017. PMID: 28253566 Free PMC article.
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody.
Suh KJ, Kim SH, Kim YJ, Kim M, Keam B, Kim TM, Kim DW, Heo DS, Lee JS. Suh KJ, et al. Among authors: kim yj, kim dw, kim sh, kim m, kim tm. Cancer Immunol Immunother. 2018 Mar;67(3):459-470. doi: 10.1007/s00262-017-2092-x. Epub 2017 Dec 4. Cancer Immunol Immunother. 2018. PMID: 29204702 Free PMC article.
Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07.
Kim M, Keam B, Ock CY, Kim SH, Kim YJ, Lim SM, Kim JS, Kim TM, Hong SH, Ahn MS, Shin SH, Kang EJ, Kim DW, Im SW, Kim JI, Lee JS, Kim JH, Heo DS. Kim M, et al. Among authors: kim ji, kim yj, kim dw, kim sh, kim js, kim tm, kim jh. Thorac Cancer. 2020 Dec;11(12):3482-3489. doi: 10.1111/1759-7714.13684. Epub 2020 Oct 7. Thorac Cancer. 2020. PMID: 33026712 Free PMC article. Clinical Trial.
Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Jung EH, Jang HR, Kim SH, Suh KJ, Kim YJ, Lee JH, Chung JH, Kim M, Keam B, Kim TM, Kim DW, Heo DS, Lee JS. Jung EH, et al. Among authors: kim yj, kim dw, kim sh, kim m, kim tm. Thorac Cancer. 2021 Mar;12(5):619-630. doi: 10.1111/1759-7714.13834. Epub 2021 Jan 17. Thorac Cancer. 2021. PMID: 33458968 Free PMC article.
12,927 results
You have reached the last available page of results. Please see the User Guide for more information.